Neptune Technologies Reports Record FY08 Q4 and Year End Results

... antioxidants. Acasti is focusing initially on treatments for chronic cardiovascular conditions. Neither NASDAQ nor TSX Venture Exchange accepts responsibility for the adequacy or accuracy of this press release. Statements ...